SuperTalk Mississippi
News

MSDH reports two new cases of vaping-related lung illness

Image courtesy of the FDA

The Mississippi State Department of Health (MSDH) is reporting two additional cases of a vaping-related lung illness in Mississippi, bringing the state’s total up to nine with one death. Most of the identified cases have been in individuals between 18 and 34 years of age, with two being in adults 35 years of age or older.

Nationwide, as of October 29, there have been 1,888 cases of lung illness reported from 49 states, the District of Columbia, and one U.S. territory. Thirty-seven deaths have been reported from 24 states.

While many of the cases in the U.S. report vaping cannabis products, such as tetrahydrocannabinol (THC), in addition to nicotine products, no specific product such as the device, liquid, refill pods or cartridge has been clearly identified as the cause of illness.

Symptoms of severe vaping-related lung illness include cough, shortness of breath, chest pain, nausea or vomiting, diarrhea, fever and fatigue. Symptoms develop anywhere from over a few days of use to weeks of using e-cigarettes.

Until an exact cause of the illness has been determined, the CDC recommends the following actions:

  • Refrain from using all e-cigarette or vaping products to ensure that you are not at risk.
  • If you are an adult who used e-cigarettes containing nicotine to quit cigarette smoking, do not return to smoking cigarettes.
  • If you have recently used an e-cigarette or vaping product and you have symptoms like those reported above, see your healthcare provider.

Additionally, Mississippians are urged to not buy products off the street containing THC or other cannabinoids.

Do not modify or add substances to e-cigarette products that are not intended by the manufacturer.

Stay up to date with all of Mississippi’s latest news by signing up for our free newsletter here

Copyright 2024 SuperTalk Mississippi Media. All rights reserved.

Related posts

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More